Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Plas

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|June 12, 2013
Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinomaDusten Unruh, Kevin Turner, Ramprasad Srinivasan, et al.
Molecular Cancer Therapeutics|September 3, 2017
mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac ImpairmentMelissa A Orr-Asman, Zhengtao Chu, Min Jiang, et al.
Plos One|May 16, 2025
CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma linesMatthew C Garrett, Troy Carnwath, Rebecca Albano, et al.
Surgical Neurology International|June 3, 2026
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature reviewNatalie Ivey, Jeff F Zhang, Abigail Zack, et al.
Scientific Reports|August 1, 2023
HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant gliomaMatthew C Garrett, Rebecca Albano, Troy Carnwath, et al.
Cell|February 5, 2013
Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesisLi Ma, Yongzhen Tao, Angeles Duran, et al.
Cancer Research Communications|August 1, 2024
Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient GlioblastomaCatherine A Behrmann, Kelli N Ennis, Pranjal Sarma, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinomaMegan E Bischoff, Behrouz Shamsaei, Juechen Yang, et al.
The Journal of Clinical Investigation|September 24, 2020
Tobacco smoking induces metabolic reprogramming of renal cell carcinomaJames Reigle, Dina Secic, Jacek Biesiada, et al.
Molecular Cancer Research : MCR|July 16, 2017
Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive CellsChenggang Li, Xiaolei Liu, Yang Liu, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|June 12, 2013
Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinomaDusten Unruh, Kevin Turner, Ramprasad Srinivasan, et al.
Molecular Cancer Therapeutics|September 3, 2017
mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac ImpairmentMelissa A Orr-Asman, Zhengtao Chu, Min Jiang, et al.
Plos One|May 16, 2025
CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma linesMatthew C Garrett, Troy Carnwath, Rebecca Albano, et al.
Surgical Neurology International|June 3, 2026
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature reviewNatalie Ivey, Jeff F Zhang, Abigail Zack, et al.
Scientific Reports|August 1, 2023
HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant gliomaMatthew C Garrett, Rebecca Albano, Troy Carnwath, et al.
Cell|February 5, 2013
Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesisLi Ma, Yongzhen Tao, Angeles Duran, et al.
Cancer Research Communications|August 1, 2024
Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient GlioblastomaCatherine A Behrmann, Kelli N Ennis, Pranjal Sarma, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinomaMegan E Bischoff, Behrouz Shamsaei, Juechen Yang, et al.
The Journal of Clinical Investigation|September 24, 2020
Tobacco smoking induces metabolic reprogramming of renal cell carcinomaJames Reigle, Dina Secic, Jacek Biesiada, et al.
Molecular Cancer Research : MCR|July 16, 2017
Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive CellsChenggang Li, Xiaolei Liu, Yang Liu, et al.
Pageof 7